netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
12.02.03  Expand sub section  Nasal preparations for infection
12.02.03  Expand sub section  Nasal Staphylococci
Bismuth subnitrate & iodoform gauze
Formulary  
   
Chloramphenicol 1% eye ointment  (ENT post surgery - off-label)
View adult BNF View SPC online
Formulary

Approved off-label indication:

Topical use post ENT surgery

Applied twice daily for a short course post-procedure

 
   
Mupirocin 2% nasal ointment
View adult BNF View SPC online
Formulary USE ON MICROBIOLOGY/VIROLOGY ADVICE 
   
Naseptin cream
View adult BNF View SPC online
Formulary

USE ON MICROBIOLOGY/VIROLOGY ADVICE Contains:

  • Chlorhexidine hydrochloride 0.1%
  • Neomycin sulphate 0.5%

Caution: also contains arachis oil (peanut oil)

 
   
Octenidine nasal gel
Formulary
Red
USE ON MICROBIOLOGY/VIROLOGY ADVICE 
   
Polyfax eye ointment
View adult BNF
Restricted Drug Restricted

USE ON MICROBIOLOGY/VIROLOGY ADVICE only - for eradication of nasal carriage of MRSA

Contains:

  • Polymixin B sulphate 10 000units/g
  • Bacitaricin zinc 500 units/g

Instructions:

  • Eye ointment is used in the nose
  • A matchhead size portion to be applied into each nostril
  • Close nostrils to spread the ointment throughout the nares
  • Dose = 2-3 times daily
  • Continue treatment for 5-7 days
 
   
Alkaline nasal douche
Unlicensed Drug Unlicensed

Powder containing:

  • Sodium bicarbonate 20g
  • Sodium chloride 20g
  • Borax 20g

Indications:

  • Post-operatively after nasal surgery and functional endoscopic sinus surgery.
  • For any condition causing crusting of nasal cavities

Instructions for use:

  • 5 mL spoonful of powder added to a tumblerful of warm water and mixed well.
  • Small aliquots of the solution are sniffed.
  • Any solution that goes into the throat should not be swallowed
  • Dose = three times daily
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary